A man raised £9,000 for a hospice by having a pre-Christmas head shave. Phil Shaw decided to raise funds for Tynedale Hospice at Home after they supported his wife Lorraine. Ms Shaw was diagnosed with ...

Scientists have developed a machine learning tool that can predict how an aggressive type of breast cancer will respond to treatment, and when it will return. Invasive lobular carcinoma (ILC ...

Auckland radiologist Dr Remy Lim is inviting Kiwis who’ve recently been diagnosed with lobular breast cancer to take part in a new clinical trial funded by Breast Cancer Foundation NZ.

Scientists have developed a machine learning tool that can predict how an aggressive type of breast cancer will respond to treatment, and when it will return. Invasive lobular carcinoma (ILC) – which ...

Ruxolitinib phosphate is under clinical development by Incyte and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Associated Cytokine Release Syndrome.

October 15th is Lobular Breast Cancer Awareness day. Important for a type of invasive breast cancer that is often difficult ...

Ruxolitinib phosphate is under clinical development by Novartis and currently in Phase II for Coronavirus Disease 2019 (COVID-19).